Medical Center, Houston
Memorial Hermann Memorial City Medical Center
921 Gessner Rd, Houston, TX 77024, Medical Center, Texas, United States of America (USA)
Office hours not listed
Fee not listed
Dr. Helen Heslop
Medical degree, DO, Fellowship in Pediatric Hematology-Oncology, M.D., Advanced Training, Advanced Training, M.B.,Ch.B., Bachelor, Internship, Fellowship 2, Fellowship, Research Fellowship, Doctor of Medicine with Distinction
Pediatrician
Registration listed: Texas Medical Board · L1610
Speaks English
Practices
Office hours are listed by the practice and are not appointment slots. Confirm fees, timings and address before visiting.
61 Services
- Erythropoietin Test
- Chronic Myeloid Leukemia (CML)
- Cancer and Blood Disorders
- Primary Central Nervous System Lymphoma
- Purpura
- Genetic modification of cytotoxic T lymphocytes (CTLs)
View all (61)
- Hematologic Malignancy
- Acute Lymphoid Leukemia
- Immunotherapy of malignancies with antigen specific T cells
- Plasmapheresis
- Bone Marrow Aspiration
- Mantle Cell Lymphoma
- Coagulation Disorders
- Diagnosis and treatment of Epstein Barr virus-induced lymphoproliferative disease
- HPC Transplantation (Stem Cell Transplant)
- Cellular Therapy
- Venous Embolism and Thrombosis
- Lymphoma, Large-Cell
- Lymphoma Evaluation
- Bleeding Disorders
- Osteosarcoma
- Leukemia Diagnostic Evaluations
- Anemia Treatment
- Myelodysplastic Syndromes
- Bone Marrow Transplant
- Bone Marrow Biopsy
- Development and clinical trials of gene-modified effector cells
- Oral Cancer Screening
- Immune Thrombocytopenic Purpura (ITP)
- Non-Hodgkin's Lymphoma
- Graft vs Host Disease
- Immunotherapy with antigen specific T cells to prevent and treat viral infections post transplant
- Acute Leukemia
- Hodgkin's Disease
- Pancytopenia
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- Amyloidosis
- Skin Screenings
- Multiple Myeloma
- Lymphosarcoma
- Brain cancer
- Osteosarcoma Treatment
- Acute Myeloid Leukemia
- Anemia and Iron Deficiency Screening
- Adoptive immunotherapy for malignancy and viral infections
- Chronic Fatigue Syndrome
- Targeting of CD19+ve, CD30+ve and her2neu+ve malignancies with transduced CTLs
- Reconstituting antiviral immunity post transplant
- Reticulosarcoma
- ANEMIA
- Cancer Screening
- bone cancer treatment
- Cell and Gene Therapy
- Peripheral T-Cell Lymphoma
- Myeloproliferative Disorders
- Diffuse Large B-Cell Lymphoma
- CAR-T Therapy
- Follicular Lymphoma Grade 1
- Leukemia
- Bone Cancer
- Neutropenia
Education
- Medical degree, DO — University Of Otago, 1990
- Fellowship in Pediatric Hematology-Oncology — St. Jude Children's Research Hospital, 1991
- M.D. — University Of Otago, 1990
- Advanced Training — The Royal Free Hospital, 1986
- Advanced Training — Christchurch Hospital, 1982
- M.B.,Ch.B. — University Of Otago, 1980
- Bachelor — University Of Otago, 1980
- Internship — Christchurch Hospital, 1983
- Fellowship 2 — The Royal Free Hospital, 1989
- Fellowship, Research Fellowship — St. Jude Children's Research Hospital, 1991
- Doctor of Medicine with Distinction — University Of Otago, 1990
Registrations
- L1610 · Texas Medical Board
- 1912087271 · National Provider Identifier (NPI)
Languages
English
Is any information incorrect?
Help us keep this profile accurate. Our team reviews every report before anything changes.
Are you Dr. Helen Heslop? Claim this profile to confirm it is you and keep it up to date.